Details

Autor(en) / Beteiligte

• Marczyk, Michal
• Qing, Tao
• O'Meara, Tess
• Yagahoobi, Vesal
• Pelekanou, Vasiliki
• Bai, Yalai
• Reisenbichler, Emily
• Cole, Kimberly S
• Li, Xiaotong
• Gunasekharan, Vignesh
• Ibrahim, Eiman
• Fanucci, Kristina
• Wei, Wei
• Rimm, David L
• Pusztai, Lajos
• Blenman, Kim R M

Titel

Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer

Ist Teil von

• NPJ breast cancer, 2022-07, Vol.8 (1), p.88-88, Article 88

Ort / Verlag

United States: Nature Publishing Group

Erscheinungsjahr

2022

Link zum Volltext

Quelle

Electronic Journals Library

Beschreibungen/Notizen

• Differences in the tumor immune microenvironment may result in differences in prognosis and response to treatment in cancer patients. We hypothesized that differences in the tumor immune microenvironment may exist between African American (AA) and NonAA patients, due to ancestry-related or socioeconomic factors, that may partially explain differences in clinical outcomes. We analyzed clinically matched triple-negative breast cancer (TNBC) tissues from self-identified AA and NonAA patients and found that stromal TILs, PD-L1 IHC-positivity, mRNA expression of immune-related pathways, and immunotherapy response predictive signatures were significantly higher in AA samples (p < 0.05; Fisher's Exact Test, Mann-Whitney Test, Permutation Test). Cancer biology and metabolism pathways, TAM-M2, and Immune Exclusion were significantly higher in NonAA samples (p < 0.05; Permutation Test, Mann-Whitney Test). There were no differences in somatic tumor mutation burden. Overall, there is greater immune infiltration and inflammation in AA TNBC and these differences may impact response to immune checkpoint inhibitors and other therapeutic agents that modulate the immune microenvironment.